lysergic acid diethylamide has been researched along with Rheumatic Diseases in 1 studies
Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.
Rheumatic Diseases: Disorders of connective tissue, especially the joints and related structures, characterized by inflammation, degeneration, or metabolic derangement.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| HERRAIZ BALLESTERO, L | 1 |
| SIMKIN ZMUD, B | 1 |
1 other study available for lysergic acid diethylamide and Rheumatic Diseases
| Article | Year |
|---|---|
[A new antiserotonin agent in the treatment of asthma, headache, urticaria, severe colitis and rheumatic diseases].
Topics: Asthma; Colitis; Colitis, Ulcerative; Headache; Humans; Lysergic Acid Diethylamide; Rheumatic Diseas | 1961 |